These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6433044)

  • 21. Modulation of autophagy and transient receptor potential vanilloid 4 channels by montelukast in a rat model of hemorrhagic cystitis.
    Elrashidy RA; Hasan RA
    Life Sci; 2021 Aug; 278():119507. PubMed ID: 33864816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effect of ketamine against hemorrhagic cystitis in rats receiving ifosfamide.
    Ozguven AA; Yılmaz O; Taneli F; Ulman C; Vatansever S; Onag A
    Indian J Pharmacol; 2014; 46(2):147-51. PubMed ID: 24741183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.
    Link H; Neef V; Niethammer D; Wilms K
    Blut; 1981 Nov; 43(5):329-30. PubMed ID: 6799018
    [No Abstract]   [Full Text] [Related]  

  • 24. [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].
    Kunze E; Köhnecke B; Engelhardt W; Brock N; Pohl J
    Arzneimittelforschung; 1983; 33(6):853-4. PubMed ID: 6412725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
    Berrigan MJ; Marinello AJ; Pavelic Z; Williams CJ; Struck RF; Gurtoo HL
    Cancer Res; 1982 Sep; 42(9):3688-95. PubMed ID: 6809312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.
    Korkmaz A; Oter S; Deveci S; Goksoy C; Bilgic H
    J Urol; 2001 Sep; 166(3):1119-23. PubMed ID: 11490309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of prostaglandin F2 alpha for the prophylaxis of cyclophosphamide induced cystitis in rats.
    Grinberg-Funes DJ; Sheldon C; Weiss M
    J Urol; 1990 Dec; 144(6):1500-4. PubMed ID: 2231956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
    Brock N; Pohl J; Stekar J; Scheef W
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1377-87. PubMed ID: 6819957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of misoprostol cytoprotection of the bladder with cyclophosphamide (Cytoxan) therapy.
    Gray KJ; Engelmann UH; Johnson EH; Fishman IJ
    J Urol; 1986 Aug; 136(2):497-500. PubMed ID: 3090278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic and therapeutic carboprost tromethamine bladder irrigation in rats with cyclophosphamide-induced hemorrhagic cystitis.
    Kranc DM; Kim J; Straus F; Levine LA
    J Urol; 1992 Oct; 148(4):1326-30. PubMed ID: 1404668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N; Stekar J
    Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mesnum and cyclophosphamide cystitis.
    Lancet; 1980 Nov; 2(8205):1195. PubMed ID: 6107795
    [No Abstract]   [Full Text] [Related]  

  • 34. Sodium 2-mercaptoethane sulfonate protection against cyclophosphamide-induced teratogenicity in rats.
    Slott VL; Hales BF
    Toxicol Appl Pharmacol; 1986 Jan; 82(1):80-6. PubMed ID: 3080822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide-induced water intoxication: treatment with fluid restriction and 2-mercaptoethane sulfonate.
    Haas A; Chin T; Stiehm ER
    Am J Dis Child; 1986 Nov; 140(11):1094-5. PubMed ID: 3094362
    [No Abstract]   [Full Text] [Related]  

  • 36. Mesna and oxazaphosphorine cancer chemotherapy.
    Shaw IC
    Cancer Treat Rev; 1987 Dec; 14(3-4):359-64. PubMed ID: 3125971
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of mesna on urotoxic effects of selected bromosubstituted analogs of ifosfamide.
    Kuśnierczyk H; Konarski L; Kowalski P; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1997; 45(1):79-85. PubMed ID: 9090445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the compounds MV8608 and MV8612 obtained from Mandevilla velutina in the model of hemorrhagic cystitis induced by cyclophosphamide in rats.
    Santos AA; Leal PC; Edelweiss MI; Lopes TG; Calixto JB; Morrone FB; Campos MM
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):399-407. PubMed ID: 20809237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.
    Scheef W; Klein HO; Brock N; Burkert H; Günther U; Hoefer-Janker H; Mitrenga D; Schnitker J; Voigtmann R
    Cancer Treat Rep; 1979 Mar; 63(3):501-5. PubMed ID: 106965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the uroprotective efficacy of mesna and HBO treatments in cyclophosphamide-induced hemorrhagic cystitis.
    Etlik O; Tomur A; Deveci S; Pişkin I; Pekcan M
    J Urol; 1997 Dec; 158(6):2296-9. PubMed ID: 9366379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.